We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Sandra
Strauss
s.strauss@ucl.ac.uk
ICONIC
Trial Coordinator
ctc.iconic@ucl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Malignant neoplasms of bone and articular cartilage
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
There has been little improvement in outcome for patients with osteosarcoma (OS) over the last 20 years. There have been only a few clinical trials of new treatments and no major new therapies introduced recently. This is in part because we do not have a good understanding of the biology of osteosarcoma, but also trials have only included subgroups of patients. The more we understand about how and why osteosarcoma arises and grows the better we will be able to decide what treatments are most likely to work best.
The purpose of this project is to collect high quality clinical data about patients of all ages with osteosarcoma, such as information about the size of the disease, how it was diagnosed and where it is at diagnosis, what treatments were given and how the disease responded the treatments. We will also collect blood and tissue samples for analysis in research laboratories. By looking at the results of the laboratory findings and the clinical data together, we will start to answer the questions about why osteosarcomas arise and grow, what makes it spread, and why some patients respond to treatment better than others. As time goes on, we plan to use this information to develop clinical trials of new treatments.
Alongside this, we want to find out more about how osteosarcoma and its treatments affect the lives of those living with this disease. This information will help us to provide the most appropriate care and support that will meet the needs of each patient.
Ultimately, our aim is to improve the care and treatment of osteosarcoma patients so that they may live longer and better lives.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
• Osteosarcoma diagnosis more than three months prior to registration
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Sandra
Strauss
s.strauss@ucl.ac.uk
ICONIC
Trial Coordinator
ctc.iconic@ucl.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University College London and funded by Bone Cancer Research Trust .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 41346
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
